Actively Recruiting
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
Led by VA Office of Research and Development · Updated on 2026-03-11
250
Participants Needed
4
Research Sites
185 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research study is addressing issues related to Inflammatory bowel disease (IBD), which is a chronic autoimmune disorder that affects over 60,000 Veterans. With close monitoring and timely treatment adjustment, the investigators can stop the natural progression of IBD, improving health-related quality of life (HRQOL) and reducing flares and hospitalizations. However, it is difficult to closely monitor Veterans with IBD between clinic visits. There is a critical need for solutions that support close between visit monitoring of Veterans with IBD. The Measurement-Based Care (MBC) for IBD study will take a systematic approach to collect, share, and act on patient reported outcome (PRO) data that can be used to achieve close monitoring. MBC supports patients' in managing their condition and boosting their confidence in their ability to handle their symptoms and disease, and also supports care teams in early recognition of health issues. The investigators will work with both Veterans and their care teams to understand and assess this program so it can be a model for future initiatives.
CONDITIONS
Official Title
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Receiving care for Inflammatory Bowel Disease (IBD) at one of the four study sites
- Reporting impaired IBD-specific quality of life using the Short IBD Questionnaire (SIBDQ <60)
- Willingness and ability to participate in study procedures
- Relevant clinic staff involved in MBC in IBD at the four study sites
You will not qualify if you...
- Presence of an ostomy or ileal-pouch anal anastomosis
- Severe comorbid medical conditions that may affect patient-reported outcomes and treatment (e.g., cancer, transplant)
- Clinic staff without any experience with MBC in IBD
- Exclusions can be determined by chart review and baseline patient assessment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Atlanta VA Medical and Rehab Center, Decatur, GA
Decatur, Georgia, United States, 30033-4004
Not Yet Recruiting
2
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States, 48105-2303
Actively Recruiting
3
VA Portland Health Care System, Portland, OR
Portland, Oregon, United States, 97207-2964
Not Yet Recruiting
4
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States, 77030-4211
Not Yet Recruiting
Research Team
S
Shirley Cohen-Mekelburg, MD MS
CONTACT
N
Nicolle Marinec, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here